Gilead Sciences reported $1000K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Amgen AMGN:US $ 31989M 112M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Coherus Biosciences CHRS:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M
YTE INCY:US $ 0.22M 0M